Free Trial

Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of "Hold" by Analysts

Teladoc Health logo with Medical background

Shares of Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) have been given a consensus rating of "Hold" by the eighteen research firms that are currently covering the stock, MarketBeat reports. Twelve research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $18.22.

Several equities research analysts have recently commented on TDOC shares. SVB Leerink began coverage on shares of Teladoc Health in a research report on Monday, February 26th. They set a "market perform" rating and a $17.00 price target for the company. Oppenheimer dropped their target price on shares of Teladoc Health from $26.00 to $21.00 and set an "outperform" rating for the company in a research report on Friday, April 26th. Citigroup cut their target price on Teladoc Health from $21.00 to $19.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 21st. Piper Sandler lowered their price target on Teladoc Health from $30.00 to $25.00 and set an "overweight" rating for the company in a research note on Wednesday, February 21st. Finally, Wells Fargo & Company reduced their price objective on shares of Teladoc Health from $17.00 to $15.00 and set an "equal weight" rating on the stock in a research note on Monday, April 29th.

Check Out Our Latest Stock Analysis on TDOC

Teladoc Health Price Performance

TDOC traded up $0.05 during trading on Friday, hitting $10.00. The company's stock had a trading volume of 3,954,953 shares, compared to its average volume of 3,925,075. The company has a quick ratio of 3.74, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $1.70 billion, a price-to-earnings ratio of -7.09 and a beta of 0.99. The firm's 50 day moving average price is $12.36 and its two-hundred day moving average price is $16.35. Teladoc Health has a 12 month low of $9.79 and a 12 month high of $30.41.


Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The firm had revenue of $646.13 million for the quarter, compared to analyst estimates of $637.31 million. During the same period in the prior year, the company posted ($0.37) EPS. The firm's quarterly revenue was up 2.7% compared to the same quarter last year. Sell-side analysts forecast that Teladoc Health will post -1.05 earnings per share for the current fiscal year.

Insider Activity

In other Teladoc Health news, insider Laizer Kornwasser sold 10,411 shares of the business's stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $132,115.59. Following the transaction, the insider now owns 86,070 shares of the company's stock, valued at approximately $1,092,228.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Laizer Kornwasser sold 10,411 shares of the firm's stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $132,115.59. Following the completion of the sale, the insider now directly owns 86,070 shares of the company's stock, valued at $1,092,228.30. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Michael Willem Waters sold 5,793 shares of Teladoc Health stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $73,513.17. Following the transaction, the chief operating officer now owns 64,881 shares of the company's stock, valued at $823,339.89. The disclosure for this sale can be found here. Insiders have sold 40,650 shares of company stock worth $521,043 over the last ninety days. Insiders own 0.95% of the company's stock.

Hedge Funds Weigh In On Teladoc Health

Large investors have recently modified their holdings of the stock. Parallel Advisors LLC lifted its holdings in Teladoc Health by 14.6% during the 4th quarter. Parallel Advisors LLC now owns 4,038 shares of the health services provider's stock worth $87,000 after purchasing an additional 515 shares during the last quarter. M&T Bank Corp raised its stake in Teladoc Health by 5.5% in the 4th quarter. M&T Bank Corp now owns 11,152 shares of the health services provider's stock worth $241,000 after purchasing an additional 584 shares in the last quarter. Van ECK Associates Corp boosted its holdings in Teladoc Health by 20.3% in the 4th quarter. Van ECK Associates Corp now owns 3,589 shares of the health services provider's stock valued at $77,000 after purchasing an additional 606 shares during the period. Victory Capital Management Inc. increased its holdings in shares of Teladoc Health by 4.3% during the third quarter. Victory Capital Management Inc. now owns 17,946 shares of the health services provider's stock worth $334,000 after purchasing an additional 748 shares during the period. Finally, Ignite Planners LLC raised its position in shares of Teladoc Health by 6.9% in the first quarter. Ignite Planners LLC now owns 13,307 shares of the health services provider's stock valued at $198,000 after buying an additional 857 shares in the last quarter. 76.82% of the stock is owned by institutional investors.

Teladoc Health Company Profile

(Get Free Report

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Featured Stories

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Should you invest $1,000 in Teladoc Health right now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

CPI News Breakdown: Key Market Moves to Follow
Understanding Oversold Stocks
Inside Pelosi’s Latest Stock Moves

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines